Milestone Scientific (MLSS) closed at $0.31 on October 23, 2026, down 2.2% from the previous close, on volume of 47,970 shares (30-day average 87,020).
Data as of October 23, 2026.
23-Oct-2026
Milestone Scientific Highlights Building a Scalable Growth Platform for CompuFlo Medical Business
Globe Newswire (Tue, 29-Sep 8:30 AM ET)
Globe Newswire (Wed, 16-Sep 9:00 AM ET)
Globe Newswire (Wed, 26-Aug 9:00 AM ET)
Milestone Scientific Reports Financial Results for Second Quarter 2026
Globe Newswire (Fri, 14-Aug 7:30 AM ET)
Milestone Scientific Schedules Second Quarter 2026 Financial Results Conference Call
Globe Newswire (Thu, 6-Aug 8:47 AM ET)
Globe Newswire (Tue, 4-Aug 8:30 AM ET)
MLSS Bolsters Balance Sheet with $2.15 Million Private Placement and Strong Board Participation
Market Chameleon (Tue, 21-Apr 7:10 AM ET)
Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.
Milestone Scientific trades on the AMEX stock market under the symbol MLSS.
As of October 23, 2026, MLSS stock price declined to $0.31 with 47,970 million shares trading.
MLSS has a beta of 1.07, meaning it tends to be more sensitive to market movements. MLSS has a correlation of 0.03 to the broad based SPY ETF.
MLSS has a market cap of $27.64 million. This is considered a Sub-Micro Cap stock.
Last quarter Milestone Scientific reported $3 million in Revenue and -$.01 earnings per share. This beat revenue expectation by $141,000 and met earnings estimates .
In the last 3 years, MLSS traded as high as $1.39 and as low as $.22.
The top ETF exchange traded funds that MLSS belongs to (by Net Assets): VTI, VXF, BUSM.
MLSS has underperformed the market in the last year with a price return of -28.3% while the SPY ETF gained +14.3%. MLSS has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -24.1% and -12.9%, respectively, while the SPY returned +3.2% and -2.4%, respectively.
MLSS support price is $.29 and resistance is $.33 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MLSS shares will trade within this expected range on the day.
